Adial Pharmaceuticals shares are trading higher after the company announced that it was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.